Reporting of Safety Events during Anti-VEGF Treatment: Pharmacovigilance in a Noninterventional Trial

Table 4

Cox proportional hazard regression for occurrence of any AE.

Parameter	Estimate	Standard error	value	Hazard ratio
Sex	−0.091	0.063	0.147	0.913
Baseline visual acuity	−0.005	0.001	<0.001	0.995
Age	0.012	0.003	<0.001	1.012
BMI	0.013	0.007	0.076	1.013
Indication	0.215	0.043	<0.001	1.240
Physician location	−0.382	0.081	<0.001	0.682

AE, adverse event; BMI, body mass index.